Related Experiment Videos
Plasmapheresis in rheumatic diseases.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1986
Summary
Apheresis, an advanced treatment for severe rheumatic diseases, shows promise in specific cases. Ongoing technological advancements aim to refine its application and deepen understanding of these complex conditions.
Area of Science:
- Rheumatology
- Immunology
- Medical Technology
Background:
- Refractory rheumatic diseases present serious complications.
- Apheresis is an innovative but expensive therapeutic option.
- Current apheresis indications are limited to selected cases.
Purpose of the Study:
- To explore the potential of apheresis in managing refractory rheumatic diseases.
- To investigate technological advancements in apheresis for improved efficacy.
- To enhance the understanding of rheumatic disease mechanisms through apheresis.
Main Methods:
- Review of current apheresis techniques and their application in rheumatology.
- Analysis of technological improvements in plasma fraction and lymphocyte subset removal.
- Evaluation of potential shifts in apheresis indications based on new data.
Main Results:
- Apheresis can be beneficial in selected patients with refractory rheumatic diseases.
- Technological advancements are crucial for expanding apheresis capabilities.
- Further research is needed to fully elucidate the role of apheresis.
Conclusions:
- Apheresis is a valuable, albeit costly, tool for specific rheumatic conditions.
- Technological progress is expected to broaden the use and knowledge base of apheresis.
- Future studies will likely redefine apheresis indications and disease insights.